The 15-minute test runs on the Diasorin Liaison Nes system and obviates the need for molecular confirmation of negative rapid immunoassay results.
Group B streptococcus (GBS) is a bacteria about 25% of pregnant women carry. It's rare for babies to get GBS disease from their mothers during labor, but it can be very harmful. So healthcare ...
ABBOTT PARK, Ill., Oct. 25, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has cleared its next-generation Influenza A & B 2 and Strep A 2 ...
Nexsen Biotech Pty Ltd. developed a rapid diagnostic test for Group B Streptococcus, a highly prevalent and potentially fatal bacteria that is the single largest maternal health problem faced by ...
SAN DIEGO, Dec. 9, 2020 /PRNewswire/ -- Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious disease diagnosis, today announced it has received 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results